APA (7th ed.) Citation

Ko, S., Jo, M., Kyung, M., Lee, W., Ko, W. H., Na, J., . . . Jung, S. T. Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential. BMC.

Chicago Style (17th ed.) Citation

Ko, Sanghwan, Migyeong Jo, Munsu Kyung, Wonju Lee, Woo Hyung Ko, Jung-Hyun Na, Youn Seo Chun, Byoung Joon Ko, and Sang Taek Jung. Engineering FcRn Binding Kinetics Dramatically Extends Antibody Serum Half-life and Enhances Therapeutic Potential. BMC.

MLA (9th ed.) Citation

Ko, Sanghwan, et al. Engineering FcRn Binding Kinetics Dramatically Extends Antibody Serum Half-life and Enhances Therapeutic Potential. BMC.